• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性期反应物作为头颈部癌症放射性粘膜炎的客观生物标志物。

Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer.

机构信息

Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.

出版信息

Head Neck. 2012 Jul;34(7):985-93. doi: 10.1002/hed.21848. Epub 2011 Sep 26.

DOI:10.1002/hed.21848
PMID:21953802
Abstract

BACKGROUND

Current evaluation of radiation-induced mucositis in head and neck cancer relies on subjective scoring with interrater variability. We evaluated serum erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) as objective markers of radiation-induced mucositis.

METHODS

Weekly serum CRP and ESR levels were measured in patients treated for head and neck cancer with radiation ± chemotherapy. Acute radiation toxicity was evaluated using National Cancer Institute of Canada-Common Toxicity Criteria (NCIC-CTC) version 2.0 and the Head and Neck Radiotherapy Questionnaire (HNRQ).

RESULTS

ESR and CRP levels were significantly elevated by 3 weeks (p = .01) and 6 weeks (p = .0002), respectively, and independent of age or pretreatment surgery. ESR was significantly dependent on radiation dose (p = .0004) and significantly higher with chemoradiation (p = .03).

CONCLUSION

Serum ESR and CRP rise reliably in a radiation dose-dependent manner. ESR correlated with clinical symptoms and distinguished patients receiving chemoradiation. ESR and CRP may be an objective and sensitive marker of radiation-induced mucositis.

摘要

背景

目前对头颈癌放射性粘膜炎的评估依赖于具有观察者间变异性的主观评分。我们评估了血清红细胞沉降率(ESR)和 C 反应蛋白(CRP)作为放射性粘膜炎的客观标志物。

方法

每周测量接受头颈部癌症放射治疗±化疗的患者的血清 CRP 和 ESR 水平。使用加拿大国家癌症研究所-常见毒性标准(NCIC-CTC)版本 2.0 和头颈部放射治疗问卷(HNRQ)评估急性放射毒性。

结果

ESR 和 CRP 水平分别在第 3 周(p =.01)和第 6 周(p =.0002)显著升高,且与年龄或术前手术无关。ESR 与辐射剂量显著相关(p =.0004),且放化疗时显著更高(p =.03)。

结论

血清 ESR 和 CRP 以辐射剂量依赖性的方式可靠地升高。ESR 与临床症状相关,并可区分接受放化疗的患者。ESR 和 CRP 可能是放射性粘膜炎的客观和敏感标志物。

相似文献

1
Acute-phase response reactants as objective biomarkers of radiation-induced mucositis in head and neck cancer.急性期反应物作为头颈部癌症放射性粘膜炎的客观生物标志物。
Head Neck. 2012 Jul;34(7):985-93. doi: 10.1002/hed.21848. Epub 2011 Sep 26.
2
C-reactive protein levels and radiation-induced mucositis in patients with head-and-neck cancer.头颈部癌患者的C反应蛋白水平与放射性黏膜炎
Int J Radiat Oncol Biol Phys. 2009 Oct 1;75(2):393-8. doi: 10.1016/j.ijrobp.2008.11.012. Epub 2009 Apr 11.
3
Phase II clinical trial of local use of GM-CSF for prevention and treatment of chemotherapy- and concomitant chemoradiotherapy-induced severe oral mucositis in advanced head and neck cancer patients: an evaluation of effectiveness, safety and costs.局部应用粒细胞巨噬细胞集落刺激因子预防和治疗晚期头颈癌患者化疗及同步放化疗所致严重口腔黏膜炎的II期临床试验:有效性、安全性及成本评估
Oncol Rep. 2003 Jan-Feb;10(1):197-206.
4
Phase II study of palifermin and concurrent chemoradiation in head and neck squamous cell carcinoma.帕利夫明与同步放化疗联合治疗头颈部鳞状细胞癌的II期研究。
J Clin Oncol. 2008 May 20;26(15):2489-96. doi: 10.1200/JCO.2007.13.7349.
5
Value of acute-phase reactants in monitoring disease activity and treatment response in idiopathic retroperitoneal fibrosis.急相反应物在特发性腹膜后纤维化疾病活动监测和治疗反应中的价值。
Nephrol Dial Transplant. 2012 Jul;27(7):2819-25. doi: 10.1093/ndt/gfr779. Epub 2012 Jan 23.
6
Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.局部晚期头颈癌患者每周使用卡铂/紫杉醇同步放化疗联合或不联合每日皮下注射氨磷汀的随机2期研究。
Cancer. 2009 Oct 1;115(19):4514-23. doi: 10.1002/cncr.24525.
7
Gabapentin for the treatment of pain syndrome related to radiation-induced mucositis in patients with head and neck cancer treated with concurrent chemoradiotherapy.用于治疗头颈部癌症患者同期放化疗后放射性黏膜炎相关疼痛综合征的加巴喷丁。
Cancer. 2010 Sep 1;116(17):4206-13. doi: 10.1002/cncr.25274.
8
Therapeutic effect of recombinant human epidermal growth factor (RhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer: a double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial.重组人表皮生长因子(RhEGF)对接受放疗(无论是否联合化疗)的头颈癌患者黏膜炎的治疗效果:一项双盲、安慰剂对照的前瞻性2期多机构临床试验。
Cancer. 2009 Aug 15;115(16):3699-708. doi: 10.1002/cncr.24414.
9
Effects of treatment intensification on acute local toxicity during radiotherapy for head and neck cancer: prospective observational study validating CTCAE, version 3.0, scoring system.治疗强化对头颈部癌放疗期间急性局部毒性的影响:验证CTCAE 3.0版评分系统的前瞻性观察研究
Int J Radiat Oncol Biol Phys. 2008 Feb 1;70(2):330-7. doi: 10.1016/j.ijrobp.2007.06.022. Epub 2007 Sep 19.
10
Risk-scoring system for predicting mucositis in patients of head and neck cancer receiving concurrent chemoradiotherapy [rssm-hn].预测接受同步放化疗的头颈癌患者黏膜炎的风险评分系统[rssm-hn]
J Cancer Res Ther. 2010 Oct-Dec;6(4):448-51. doi: 10.4103/0973-1482.77100.

引用本文的文献

1
Nasopharyngeal necrosis contributes to overall survival in nasopharyngeal carcinoma without distant metastasis: a comprehensive nomogram model.鼻咽坏死与无远处转移鼻咽癌的总生存有关:一个综合的列线图模型。
Eur Radiol. 2023 May;33(5):3682-3692. doi: 10.1007/s00330-023-09431-4. Epub 2023 Feb 3.
2
Phytochemical-rich vegetable and fruit juice alleviates oral mucositis during concurrent chemoradiotherapy in patients with locally advanced head and neck cancer.富含植物化学物质的蔬菜和果汁可缓解局部晚期头颈癌患者同步放化疗期间的口腔黏膜炎。
J Tradit Complement Med. 2022 Mar 25;12(5):488-498. doi: 10.1016/j.jtcme.2022.03.004. eCollection 2022 Sep.
3
Inflammation-based Prognostic Score as a Prognostic Biomarker in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma Treated With Nivolumab Therapy.
基于炎症的预后评分作为接受纳武利尤单抗治疗的复发性和/或转移性头颈部鳞状细胞癌患者的预后生物标志物。
In Vivo. 2022 Mar-Apr;36(2):907-917. doi: 10.21873/invivo.12780.
4
Oral mucositis: the hidden side of cancer therapy.口腔黏膜炎:癌症治疗的隐匿面。
J Exp Clin Cancer Res. 2020 Oct 7;39(1):210. doi: 10.1186/s13046-020-01715-7.
5
The development of a nomogram to predict post-radiation necrosis in nasopharyngeal carcinoma patients: a large-scale cohort study.预测鼻咽癌患者放疗后坏死的列线图的开发:一项大规模队列研究。
Cancer Manag Res. 2019 Jul 8;11:6253-6263. doi: 10.2147/CMAR.S197841. eCollection 2019.
6
Predicting treatment Response based on Dual assessment of magnetic resonance Imaging kinetics and Circulating Tumor cells in patients with Head and Neck cancer (PREDICT-HN): matching 'liquid biopsy' and quantitative tumor modeling.基于头颈部癌症患者磁共振成像动力学和循环肿瘤细胞双重评估的治疗反应预测(PREDICT-HN):“液体活检”与定量肿瘤模型匹配。
BMC Cancer. 2018 Sep 19;18(1):903. doi: 10.1186/s12885-018-4808-5.
7
Association Between Inflammatory Biomarker C-Reactive Protein and Radiotherapy-Induced Early Adverse Skin Reactions in a Multiracial/Ethnic Breast Cancer Population.炎症生物标志物 C 反应蛋白与多民族/族裔乳腺癌人群放疗诱导的早期皮肤不良反应的相关性。
J Clin Oncol. 2018 Aug 20;36(24):2473-2482. doi: 10.1200/JCO.2017.77.1790. Epub 2018 Jul 10.
8
Effect of surgery and radiotherapy on complete blood count, lymphocyte subsets and inflammatory response in patients with advanced oral cancer.手术和放疗对晚期口腔癌患者全血细胞、淋巴细胞亚群和炎症反应的影响。
BMC Cancer. 2018 Mar 1;18(1):235. doi: 10.1186/s12885-018-4136-9.
9
Biomarkers in the assessment of oral mucositis in head and neck cancer patients: a systematic review and meta-analysis.生物标志物在头颈部癌患者口腔黏膜炎评估中的应用:一项系统综述和荟萃分析。
Support Care Cancer. 2017 Sep;25(9):2969-2988. doi: 10.1007/s00520-017-3783-8. Epub 2017 Jun 16.
10
Oral shedding of human herpesviruses in patients undergoing radiotherapy/chemotherapy treatment for head and neck squamous cell carcinoma.头颈部鳞状细胞癌患者接受放化疗治疗时的人类疱疹病毒经口排出。
Clin Oral Investig. 2017 Sep;21(7):2291-2301. doi: 10.1007/s00784-016-2022-x. Epub 2016 Dec 14.